New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
14:51 EDTTKMRTekmira volatility elevated on wide price movement
Tekmira August call option implied volatility is at 133, September is at 110, December is at 94, March is at 98; compared to its 15-week average of 99 according to Track Data, suggesting large near term price movement.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
13:24 EDTTKMRLiberia, U.S. begin ZMapp ebola trial
In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study may be expanded to test ZMapp against other treatments which may also include the following: Tekmira siRNA from Tekmira Pharmaceuticals (TKMR), Favipiravir from Toyama Chemical, BCX4430 from BioCryst (BCRX), and AVI-7537 from Sarepta (SRPT). The trial is expected to conclude in December 2016.
February 26, 2015
11:32 EDTTKMRTekmira to host special shareholder meeting
Subscribe for More Information
05:27 EDTTKMRTekmira announces update to proxy circular on merger with OnCore
Tekmira Pharmaceuticals announced an update to persons who will serve as members of the board of the company upon completion of the company's proposed business combination with OnCore Biopharma, as described in the company's proxy circular regarding the transaction, dated February 4. The board of the combined company upon completion of the merger will consist of Vivek Ramaswamy, who will serve as chairman of the board, Mark Murray, Ph.D., Richard Henriques, Jr., Keith Manchester, Frank Karbe, William T. Symonds, Pharm. D., and Herbert Conrad. Daniel Kisner, M.D., will not serve as a director or vice chairman of the board for the combined company.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use